Journey Medical Corp

NASDAQ:DERM  
4.04
+0.47 (+13.16%)
Earnings Announcements

Journey Medical Corp Reports Full-Year 2021 Financial Results

Published: 03/23/2022 20:35 GMT
Journey Medical Corp (DERM) - Oration Reports Full-year 2021 Financial Results and Recent Corporate Highlights.
Q4 Non-GAAP Loss per Share $0.93.
Q4 Loss per Share $1.64.
Revenue is expected to be $22.82 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $23.57 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.